Crossmark

Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with nonhormonal agents: combined analysis of four phase-2 trials

Crossref DOI link: https://doi.org/10.1038/pcan.2014.44

Published Online: 2014-11-11

Published Print: 2015-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suzman, D L

Zhou, X C

Zahurak, M L

Lin, J

Antonarakis, E S
License Information

Text and Data Mining valid from 2014-11-11

Version of Record valid from 2014-11-11
More Information

Article History

Received: 26 June 2014

Revised: 28 August 2014

Accepted: 23 September 2014

First Online: 11 November 2014

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below